Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond

Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16.
No abstract available

Keywords: Abortion; COVID-19; Mifepristone; Misoprostol; Pandemic; Telehealth; Ultrasound.

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage*
  • Abortifacient Agents, Steroidal / administration & dosage*
  • Abortifacient Agents, Steroidal / therapeutic use
  • Abortion, Induced / methods*
  • Adult
  • Coronavirus
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Female
  • Humans
  • Mifepristone / administration & dosage*
  • Mifepristone / therapeutic use
  • Misoprostol / administration & dosage*
  • Misoprostol / therapeutic use
  • Pandemics*
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Practice Guidelines as Topic*

Substances

  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Misoprostol
  • Mifepristone